Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/5/14 → 5/5/20 |
Funding
- Parexel (Prot #R668-AD-1225 // Prot #R668-AD-1225)
- Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1225 // Prot #R668-AD-1225)
Prot #R668-AD-1225: An Open-Label Study of Dupilumab in Patients with Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials
- Laumann, Anne E (PD/PI)
Project: Research project